Ìý
The Visiting Speakers Program in Oncology (VSPO) is a joint program between Â鶹AV and the Université de Montréal, which sponsors internationally-renowned oncology specialists to come share their expertise with the medical community of Montreal. Invited speakers present at several Â鶹AV and Université de Montréal teaching hospitals and often at Hôpital Charles-LeMoyne (teaching hospital of Université de Sherbrooke)Ìýthus facilitating attendance by busy healthcare professionals.
To Suggest a Speaker
The duration of a speaker tour is one to three days depending on the number and schedule of the talks. A typical speaker tour includes MUHC-Glen, Jewish General Hospital and CHUM as well as one or more of the following hospitals: Hôpital Maisonneuve-Rosemont, Hôpital du Sacré Coeur, Hôpital Charles-Le Moyne. Videoconferencing to other hospitals in Quebec is available upon request. For each speaker tour, an oncologist at each site is designated as the host and introduces the speaker.
VSPO Sponsors and Montreal area healthcare professionals andÌýresearchers can suggest a speaker by completing the VSPO Speaker Suggestion Form (see link below) and submitting it to:
Tony Narine
VSPO Coordinator
vspo [at] mcgill.ca (email)Ìý
VSPO Speaker Suggestion FormÌýÌý
Ìý
Upcoming Speaker ToursÌý Ìý ÌýÌý
Becoming a VSPO SponsorÌý Ìý Ìý
This program has received an educational grant from:
AbbVie, Agence UNIK, Amgen, Astellas, AstraZeneca, Bayer, BeiGene, Bristol-MyersÌýSquibb, Eisai, EMD Serono, Forus Therapeutics, Gilead a Kite Company, GlaxoSmithKline-GSK, Ipsen Canada, Janssen, Merck,ÌýPfizer, Roche, Sanofi, Seagen Canada, Servier, Taiho Pharma, Takeda, Viatris Canada